Complete Filing Data
Oaktree Specialty Lending Corp reported Net Asset Value Per Share of 17 shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Oaktree Specialty Lending Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income Loss | $33.9M | $57.9M | $117.3M | $29.2M | $237.3M |
| Interest Expense | $115.8M | $128.6M | $111.6M | $46.9M | $30.5M |
| General And Administrative Expense | $3.6M | $2.6M | $3.5M | $3.0M | $2.7M |
| Deferred Income Tax Expense Benefit | $269.0K | -$5.0K | $1.7M | -$973.0K | $133.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $5.6M | $38.4M | -$36.2M | $7.2M | $1.1M | $9.3M | $10.5M | $36.7M | $21.5M | $13.2M | -$37.8M | $14.4M | $39.4M |
| Interest Expense | $26.7M | $31.1M | $28.2M | $30.6M | $32.5M | $31.9M | $32.2M | $30.8M | $27.8M | $20.7M | $11.9M | $9.9M | $9.4M |
| General And Administrative Expense | $841.0K | $997.0K | $937.0K | $926.0K | $824.0K | $526.0K | $591.0K | $752.0K | $1.3M | $746.0K | $811.0K | $713.0K | $693.0K |
| Deferred Income Tax Expense Benefit | $19.0K | $14.0K | -$900.0K | -$5.0K | -$900.0K | -$35.0K | -$959.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $1.52B | $1.25B | $1.31B | $914.9M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $145.5M | $26.4M | $31.6M | $39.1M | ||
| Stockholders Equity Period Increase Decrease | -$22.0M | -$28.0M | $270.2M | -$67.3M | $397.9M | |
| Dividend Income Operating Paid In Cash | $3.5M | $5.4M | $4.2M | $6.4M | $4.5M | |
| Money Market Funds Percent Of Net Assets | $0.05 | $0.02 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.1M | -$67.0M | $119.2M | -$5.3M | -$7.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $78.5M | $145.5M | $26.4M | $31.6M | ||
| Cash And Cash Equivalents At Carrying Value | $64.0M | $136.5M | $23.5M | $29.3M | ||
| Amortization Of Debt Discount Premium | $1.0M | $1.3M | $783.0K | $679.0K | $572.0K | |
| Accretion Amortization Of Discounts And Premiums Investments | $18.0M | $18.0M | $22.3M | $29.1M | $29.4M | |
| Restricted Cash | $0.00 | $14.6M | $9.1M | $2.8M | $2.3M | |
| Unsecured Debt | $928.7M | $890.7M | $601.0M | |||
| Unamortized Debt Issuance Expense | $4.9M | $7.1M | $5.0M | |||
| Retained Earnings Accumulated Deficit | -$777.5M | -$651.3M | -$582.8M | |||
| Receivables From Brokers Dealers And Clearing Organizations | $17.1M | $54.3M | $45.5M | |||
| Receivable Investment Sale | $17.5M | $55.4M | $4.7M | |||
| Payable Investment Purchase | $15.7M | $11.0M | $27.0M | |||
| Other Assets | $775.0K | $1.7M | $1.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.44B | $1.47B | $1.48B | $1.48B | $1.45B | $1.49B | $1.50B | $1.52B | $1.51B | $1.51B | $1.52B | $1.20B | $1.26B | $1.33B | $1.33B | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $80.8M | $79.6M | $79.8M | $108.2M | $126.1M | $78.5M | $107.3M | $137.5M | $131.7M | $72.7M | $53.0M | $19.2M | $36.3M | $41.8M | $46.1M | |
| Stockholders Equity Period Increase Decrease | -$29.6M | $1.4M | $25.3M | -$38.0M | -$28.0M | $12.4M | -$4.1M | -$5.7M | $313.2M | -$43.6M | -$66.8M | $5.3M | $12.2M | |||
| Dividend Income Operating Paid In Cash | $1.4M | $525.0K | $772.0K | $818.0K | $1.4M | $1.4M | $1.4M | $1.1M | $1.1M | $1.1M | $956.0K | $700.0K | $3.9M | |||
| Money Market Funds Percent Of Net Assets | $0.06 | $0.05 | $0.05 | $0.07 | $0.09 | $0.07 | $0.09 | $0.09 | $2.08 | $0.05 | $0.04 | $0.02 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.2M | $47.5M | -$13.8M | -$7.1M | $14.4M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $80.8M | $79.6M | $79.8M | $108.2M | $126.1M | $107.3M | $137.5M | $131.7M | $72.7M | $53.0M | $19.2M | |||||
| Cash And Cash Equivalents At Carrying Value | $80.8M | $79.6M | $79.8M | $97.8M | $112.9M | $96.3M | $125.0M | $112.4M | $59.7M | $43.8M | $17.4M | |||||
| Amortization Of Debt Discount Premium | $200.0K | $326.0K | $326.0K | $170.0K | $170.0K | |||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $3.6M | $4.9M | $5.3M | $5.1M | $7.1M | |||||||||||
| Restricted Cash | $0.00 | $10.4M | $13.2M | $11.0M | $12.5M | $19.3M | $13.0M | $9.3M | $1.9M | |||||||
| Unsecured Debt | $945.0M | $941.9M | $937.6M | $928.5M | $917.8M | $907.2M | $905.6M | $912.7M | $605.1M | $608.8M | $603.6M | |||||
| Unamortized Debt Issuance Expense | $6.0M | $6.6M | $7.1M | $7.6M | $4.4M | $5.5M | $6.0M | $6.5M | $3.9M | $4.3M | $4.7M | |||||
| Retained Earnings Accumulated Deficit | -$914.8M | -$885.1M | -$891.7M | -$893.1M | -$815.5M | -$769.1M | -$725.1M | -$689.7M | -$654.9M | -$649.1M | -$628.3M | |||||
| Receivables From Brokers Dealers And Clearing Organizations | $15.6M | $15.6M | $15.6M | $25.2M | $21.9M | $30.3M | $40.6M | $26.5M | $40.0M | $45.7M | $39.8M | |||||
| Receivable Investment Sale | $9.8M | $4.9M | $11.0M | $18.5M | $55.7M | $18.8M | $20.4M | $23.9M | $39.3M | $14.4M | $8.7M | |||||
| Payable Investment Purchase | $23.2M | $15.0M | $0.00 | $110.2M | $0.00 | $51.6M | $61.0M | $57.3M | $2.8M | $0.00 | $21.0M | |||||
| Other Assets | $1.4M | $1.5M | $6.6M | $1.0M | $1.4M | $2.6M | $2.5M | $2.6M | $693.0K | $974.0K | $4.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Proceeds From Long Term Lines Of Credit | $500.0M | $255.0M | $572.0M | $300.0M | $505.0M |
| Proceeds From Disposition Of Investment Operating Activity | $1.04B | $1.09B | $912.0M | $693.7M | $792.2M |
| Payments Of Dividends Common Stock | $148.2M | $176.8M | $180.0M | $115.2M | $79.9M |
| Payments For Purchase Of Investment Operating Activity | $958.7M | $1.28B | $742.1M | $702.1M | $1.12B |
| Net Cash Provided By Used In Operating Activities | $228.4M | $19.1M | $228.8M | $22.4M | -$230.5M |
| Net Cash Provided By Used In Financing Activities | -$229.3M | -$86.8M | -$110.4M | -$26.8M | $224.2M |
| Increase Decrease In Receivables Under Repurchase Agreements | -$12.6M | -$37.9M | $50.7M | -$3.5M | -$2.5M |
| Increase Decrease In Payables Under Repurchase Agreements | -$655.0K | $4.7M | -$16.0M | $18.9M | $7.6M |
| Increase Decrease In Other Operating Assets | $720.0K | -$906.0K | -$14.0K | -$619.0K | $1.4M |
| Increase Decrease In Interest Payable Net | -$4.2M | $224.0K | $4.4M | $3.3M | $1.2M |
| Increase Decrease In Interest And Dividends Receivable | -$7.1M | -$1.6M | -$578.0K | $16.1M | $8.5M |
| Increase Decrease In Due To Affiliates | -$2.5M | -$222.0K | $408.0K | -$1.2M | $1.1M |
| Increase Decrease In Due From Portfolio Companies | $9.3M | -$6.2M | $16.3M | -$20.5M | $1.4M |
| Increase Decrease In Brokerage Receivables | -$1.5M | -$37.2M | $8.7M | $43.9M | $1.6M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$2.0M | -$458.0K | -$53.1M | $677.0K | -$426.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.1M | $701.0K | $827.0K | -$851.0K | -$1.1M |
| Payments Of Stock Issuance Costs | $43.0K | $117.0K | $235.0K | $215.0K | $0.00 |
| Increase Decrease In Management And Incentive Fees Payable | -$3.0M | -$4.0M | -$489.0K | -$16.7M | $19.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|
| Proceeds From Long Term Lines Of Credit | $225.0M | $125.0M | $20.0M | $202.0M | $70.0M |
| Proceeds From Disposition Of Investment Operating Activity | $181.8M | $352.5M | $217.6M | $108.8M | $235.0M |
| Payments Of Dividends Common Stock | $34.1M | $43.8M | $47.0M | $56.7M | $27.2M |
| Payments For Purchase Of Investment Operating Activity | $306.7M | $201.8M | $359.9M | $261.4M | $246.6M |
| Net Cash Provided By Used In Operating Activities | -$83.5M | $144.0M | $1.1M | -$109.9M | $23.2M |
| Net Cash Provided By Used In Financing Activities | $84.8M | -$95.3M | -$14.6M | $103.3M | -$7.5M |
| Increase Decrease In Receivables Under Repurchase Agreements | $4.9M | $38.1M | -$31.5M | $4.0M | $17.7M |
| Increase Decrease In Payables Under Repurchase Agreements | $8.2M | -$15.7M | $46.3M | -$6.0M | $32.7M |
| Increase Decrease In Other Operating Assets | -$142.0K | $662.0K | $905.0K | $2.5M | $564.0K |
| Increase Decrease In Interest Payable Net | -$359.0K | $1.4M | $3.0M | $5.4M | $2.1M |
| Increase Decrease In Interest And Dividends Receivable | -$8.0M | -$13.2M | -$1.5M | $1.8M | -$1.8M |
| Increase Decrease In Due To Affiliates | $89.0K | -$2.6M | -$494.0K | $80.0K | -$854.0K |
| Increase Decrease In Due From Portfolio Companies | $2.9M | $12.1M | -$1.6M | $16.3M | -$803.0K |
| Increase Decrease In Brokerage Receivables | $0.00 | $4.8M | -$27.7M | -$5.8M | $1.8M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $643.0K | -$121.0K | $323.0K | -$554.0K | $3.1M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$131.0K | -$1.2M | -$319.0K | -$475.0K | -$1.3M |
| Payments Of Stock Issuance Costs | $0.00 | $38.0K | $85.0K | $0.00 | |
| Increase Decrease In Management And Incentive Fees Payable | -$3.8M | -$6.6M | -$542.0K | $931.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $16.76 | $18.19 | $19.14 | $19.63 | $22.03 | $19.47 | $19.81 | $18.26 |
| Common Stock Shares Outstanding | 77.2M | 61.1M | 60.1M | 47.0M | 47.0M | 47.0M | ||
| Investment Company Investment Income Loss Per Share | $1.77 | $2.18 | $2.51 | $2.45 | $1.80 | $1.53 | $1.45 | |
| Weighted Average Number Of Shares Outstanding Basic | 86.1M | 80.4M | 72.1M | 60.7M | 54.0M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 86.1M | 80.4M | 72.1M | 60.7M | 54.0M | |||
| Earnings Per Share Diluted | $0.39 | $0.72 | $1.63 | $0.48 | $4.39 | |||
| Earnings Per Share Basic | $0.39 | $0.72 | $1.63 | $0.48 | $4.39 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $16.30 | $16.64 | $17.63 | $18.09 | |||||||||||
| Common Stock Shares Outstanding | 88.1M | 88.1M | 88.1M | 88.1M | 82.2M | 82.2M | 82.2M | 81.4M | 79.0M | 77.1M | 77.1M | 61.2M | 61.1M | 61.1M | 60.2M |
| Investment Company Investment Income Loss Per Share | $0.42 | $0.38 | $0.45 | $0.54 | $0.54 | $0.52 | $0.57 | $0.63 | $0.63 | $0.63 | $0.66 | $0.66 | $0.54 | ||
| Weighted Average Number Of Shares Outstanding Basic | 88.1M | 88.1M | 85.9M | 82.2M | 81.8M | 79.8M | 77.8M | 77.1M | 73.2M | 61.1M | 61.1M | 60.5M | 60.1M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 88.1M | 88.1M | 85.9M | 82.2M | 81.8M | 79.8M | 77.8M | 77.1M | 73.2M | 61.1M | 61.1M | 60.5M | 60.1M | ||
| Earnings Per Share Diluted | $0.06 | $0.44 | $-0.42 | $0.09 | $0.01 | $0.12 | $0.14 | $0.48 | $0.29 | $0.22 | $-0.62 | $0.24 | $0.66 | ||
| Earnings Per Share Basic | $0.06 | $0.44 | $-0.42 | $0.09 | $0.01 | $0.12 | $0.14 | $0.48 | $0.29 | $0.22 | $-0.62 | $0.24 | $0.66 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stock Issued During Period Value Dividend Reinvestment Plan | $10.7M | $7.2M | $5.9M | $3.4M | $2.2M |
| Realized And Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $394.0K | -$108.0K | $1.7M | $329.0K | $785.0K |
| Investment Income Operating After Expense And Tax | $152.6M | $175.1M | $180.7M | $148.6M | $97.1M |
| Investment Company Shareholder Transactions Increase Decrease | -$158.9M | -$184.0M | -$185.9M | -$118.7M | -$82.0M |
| Stock Issued During Period Value New Issues | $2.9M | $92.5M | $1.3M | $20.6M | $0.00 |
| Fee Income | $5.8M | $9.2M | $6.5M | $6.6M | $14.1M |
| Excise And Sales Taxes | $0.00 | $0.00 | $100.0K | $100.0K | $0.00 |
| Unrealized Gain Loss On Derivatives | $4.4M | -$8.8M | $59.0K | $4.9M | $1.7M |
| Unrealized Gain Loss Investment And Derivative Operating Before Tax | -$101.2M | $19.1M | -$28.6M | -$136.2M | $114.5M |
| Realized Gain Loss Investment And Derivative Operating Before Tax | -$17.1M | -$136.4M | -$33.2M | $17.2M | $26.4M |
| Professional Fees | $4.9M | $4.7M | $6.2M | $4.4M | $4.2M |
| Noninterest Expense Directors Fees | $640.0K | $640.0K | $640.0K | $603.0K | $607.0K |
| Net Investment Income | $153.5M | $175.1M | $180.8M | $151.9M | $99.9M |
| Management Fee Expense | $30.2M | $43.4M | $44.9M | $39.6M | $32.3M |
| Investment Income Investment Expense | $184.6M | $216.3M | $204.0M | $113.6M | $111.1M |
| Investment Company Voluntary Fee Waived | $933.0K | $5.3M | $5.5M | $3.0M | $1.6M |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $163.3M | $206.6M | $198.5M | $110.6M | $109.5M |
| Investment Company Capital Share Transactions Increase Decrease | $102.9M | $98.2M | $338.8M | $22.2M | $242.7M |
| Interest Income Operating Paid In Kind | $19.4M | $20.8M | $19.8M | $20.5M | $16.4M |
| Interest Income Operating Including Deposits | $288.1M | $346.2M | $348.8M | $228.9M | $174.4M |
| Interest Income Deposits With Financial Institutions | $5.2M | $6.0M | $4.1M | $452.0K | $9.0K |
| Gross Investment Income Operating | $316.8M | $381.7M | $379.3M | $262.5M | $209.4M |
| Gain Loss On Sale Of Derivatives | -$11.1M | $1.1M | -$5.8M | $13.7M | -$674.0K |
| Administrative Fees Expense Administrator Fees | $2.0M | $1.5M | $1.3M | $1.2M | $1.5M |
| Stock Repurchased During Period Value | $10.7M | $1.6M | $2.4M | $1.9M | $2.2M |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$118.7M | -$117.1M | -$63.4M | -$119.4M | $140.2M |
| Incentive Fee Expense Part I | $34.8M | $35.8M | $26.6M | $21.6M | |
| Investment Income Operating Tax Expense Benefit | $861.0K | $0.00 | $0.00 | $3.3M | $2.8M |
| Repayments Of Long Term Lines Of Credit | $665.0M | $255.0M | $787.0M | $230.0M | $529.6M |
| Interest Paid Net | $110.2M | $122.1M | $98.2M | $39.2M | $24.0M |
| Amortization Of Financing Costs | $8.8M | $5.0M | $4.6M | $3.7M | $4.2M |
| Stock Issued During Period Value Acquisitions | $0.00 | $0.00 | $334.0M | $0.00 | $242.7M |
| Line Of Credit | $710.0M | $710.0M | $700.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Dividend Reinvestment Plan | $1.1M | $3.8M | $4.3M | $1.5M | $1.9M | $1.9M | $1.9M | $1.1M | $1.3M | $1.9M | $874.0K | $800.0K | $786.0K | |
| Realized And Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $19.0K | $269.0K | -$14.0K | $139.0K | $202.0K | $175.0K | $176.0K | $86.0K | $66.0K | -$549.0K | $661.0K | $21.0K | -$2.4M | |
| Investment Income Operating After Expense And Tax | $36.7M | $33.5M | $39.1M | $44.3M | $44.6M | $41.4M | $44.2M | $48.4M | $46.0M | $38.8M | $40.4M | $40.1M | $32.3M | |
| Investment Company Shareholder Transactions Increase Decrease | -$35.2M | -$37.0M | -$41.4M | -$45.2M | -$45.2M | -$44.7M | -$48.9M | -$42.4M | -$42.4M | -$58.7M | -$30.3M | -$29.3M | -$28.0M | |
| Stock Issued During Period Value New Issues | $0.00 | $2.9M | $0.00 | $14.2M | $46.0M | $32.3M | $0.00 | $0.00 | $0.00 | $1.2M | $19.4M | |||
| Fee Income | $3.0M | $286.0K | $1.7M | $1.7M | $1.5M | $2.5M | $1.3M | $1.6M | $2.4M | $1.3M | $2.3M | $1.9M | $912.0K | |
| Excise And Sales Taxes | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $78.0K | $0.00 | $0.00 | $0.00 | |||||
| Unrealized Gain Loss On Derivatives | $118.0K | $1.9M | -$14.7M | $10.5M | $1.1M | $2.2M | -$7.8M | $4.6M | $1.6M | -$11.0M | -$1.6M | $1.7M | -$837.0K | |
| Unrealized Gain Loss Investment And Derivative Operating Before Tax | -$32.4M | $18.6M | -$82.0M | -$19.6M | $26.2M | -$25.3M | -$25.0M | -$1.0M | -$18.3M | -$23.0M | -$86.8M | -$27.0M | -$4.6M | |
| Realized Gain Loss Investment And Derivative Operating Before Tax | $1.3M | -$13.4M | $6.7M | -$17.3M | -$69.5M | -$6.6M | -$8.5M | -$10.6M | -$6.1M | -$3.2M | $9.2M | $1.4M | $9.3M | |
| Professional Fees | $1.4M | $1.4M | $1.2M | $1.1M | $1.1M | $1.2M | $1.5M | $1.4M | $2.1M | $1.5M | $885.0K | $822.0K | $1.3M | |
| Noninterest Expense Directors Fees | $160.0K | $160.0K | $160.0K | $160.0K | $160.0K | $160.0K | $160.0K | $160.0K | $160.0K | $160.0K | $160.0K | $160.0K | $123.0K | |
| Net Investment Income | $36.7M | $33.5M | $39.3M | $44.6M | $44.6M | $41.4M | $44.2M | $48.4M | $46.0M | $38.9M | $40.4M | $40.1M | $35.6M | |
| Management Fee Expense | $7.5M | $7.2M | $7.5M | $8.1M | $11.8M | $11.6M | $11.5M | $12.0M | $11.5M | $9.9M | $9.8M | $10.1M | $10.0M | |
| Investment Income Investment Expense | $38.4M | $47.1M | $45.2M | $49.2M | $55.1M | $54.2M | $55.3M | $55.0M | $52.1M | $41.0M | $23.5M | $25.0M | $30.1M | |
| Investment Company Voluntary Fee Waived | $0.00 | $0.00 | $183.0K | $750.0K | $1.5M | $1.5M | $1.5M | $1.5M | $1.8M | $750.0K | $750.0K | $750.0K | $750.0K | |
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $38.4M | $41.7M | $38.2M | $42.1M | $50.4M | $52.7M | $53.8M | $53.5M | $50.3M | $40.3M | $22.8M | $24.2M | $29.3M | |
| Investment Company Capital Share Transactions Increase Decrease | $0.00 | $0.00 | $102.9M | $0.00 | $16.1M | $47.8M | $34.2M | $0.00 | $334.0M | $1.9M | $1.2M | $20.1M | $786.0K | |
| Interest Income Operating Paid In Kind | $3.8M | $5.1M | $4.5M | $5.7M | $6.1M | $4.8M | $3.8M | $4.0M | $4.1M | $6.1M | $5.2M | $4.7M | $4.7M | |
| Interest Income Operating Including Deposits | $66.9M | $69.4M | $70.5M | $78.4M | $86.0M | $85.3M | $91.4M | $95.3M | $88.7M | $70.0M | $54.7M | $57.0M | $55.5M | |
| Interest Income Deposits With Financial Institutions | $928.0K | $1.5M | $1.6M | $1.2M | $1.2M | $1.5M | $2.4M | $992.0K | $757.0K | $472.0K | $151.0K | $5.0K | $1.0K | |
| Gross Investment Income Operating | $75.1M | $75.3M | $77.6M | $86.6M | $95.0M | $94.0M | $98.0M | $101.9M | $96.3M | $79.2M | $63.1M | $64.3M | $64.9M | |
| Gain Loss On Sale Of Derivatives | $1.2M | -$15.3M | $7.9M | $34.0K | -$289.0K | -$1.2M | $4.1M | -$6.3M | -$3.7M | $4.4M | $8.8M | $411.0K | $3.0M | |
| Administrative Fees Expense Administrator Fees | $570.0K | $525.0K | $388.0K | $437.0K | $391.0K | $326.0K | $366.0K | $322.0K | $315.0K | $298.0K | $271.0K | $307.0K | $390.0K | |
| Stock Repurchased During Period Value | $1.1M | $3.8M | $4.3M | $1.5M | $0.00 | $0.00 | $0.00 | $1.1M | $1.3M | $874.0K | $0.00 | |||
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$31.1M | $4.9M | -$75.3M | -$37.1M | -$43.5M | -$32.0M | -$33.7M | -$11.7M | -$24.5M | -$25.6M | -$78.2M | -$25.7M | ||
| Incentive Fee Expense Part I | $6.7M | $7.9M | $8.3M | $8.5M | $9.0M | $9.6M | $9.0M | $7.7M | $6.5M | $6.7M | $6.5M | |||
| Investment Income Operating Tax Expense Benefit | $17.0K | $56.0K | $278.0K | $263.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.3M | |
| Repayments Of Long Term Lines Of Credit | $105.0M | $175.0M | $20.0M | $42.0M | $50.0M | |||||||||
| Interest Paid Net | $25.7M | $27.6M | $27.6M | $14.3M | $6.2M | |||||||||
| Amortization Of Financing Costs | $1.1M | $1.3M | $1.2M | $828.0K | $924.0K | |||||||||
| Stock Issued During Period Value Acquisitions | $0.00 | $0.00 | $0.00 | $334.0M | $0.00 | $0.00 | ||||||||
| Line Of Credit | $665.0M | $545.0M | $510.0M | $520.0M | $660.0M | $790.0M | $730.0M | $710.0M | $1.14B | $1.12B | $860.0M |
Most recent annual filing with the SEC: November 18, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.